A systematic review of the efficacy of ketamine for craniofacial pain
ABSTRACTBackground Craniofacial pain (CFP) poses a burden on patients and health care systems. It is hypothesized that ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can reverse central sensitization associated with causation and propagation of CFP. This systematic review aims to asse...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Canadian Journal of Pain |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/24740527.2023.2210167 |